Silence Therapeutics plc (SLNCF) Operating income 2022–2025
Silence Therapeutics plc (SLNCF) annual operating income history from SEC filings — each fiscal year as reported.
-$91.1MFY2025 · since FY2022: -$61.0M → -$91.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$91.1M | -43.8% |
| FY2024 | -$63.3M | +1.7% |
| FY2023 | -$64.4M | -5.5% |
| FY2022 | -$61.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SLNCF financial trends
SLNCF RevenueSLNCF Net incomeSLNCF Net marginSLNCF Gross profitSLNCF Gross marginSLNCF Operating marginSLNCF Operating cash flowSLNCF Free cash flowSLNCF Capital expendituresSLNCF Return on equitySLNCF Stock buybacksSLNCF Dividends paidSLNCF Total assetsSLNCF Total liabilitiesSLNCF Shareholders’ equitySLNCF overview →